Article info

Download PDFPDF

Original research
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials

Authors

  1. Correspondence to Philip S Helliwell; p.helliwell{at}leeds.ac.uk
View Full Text

Citation

Helliwell PS, Gladman DD, Chakravarty SD, et al
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials

Publication history

  • Received November 15, 2019
  • Revision received January 7, 2020
  • Accepted January 10, 2020
  • First published February 10, 2020.
Online issue publication 
February 10, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.